Advertisement

13-Year-Old with Red, Scaly Rash

  • Michael P. Lee
  • Kevin K. Wu
  • Jashin J. Wu
Chapter
Part of the Clinical Cases in Dermatology book series (CLIDADE)

Abstract

Pediatric psoriasis has more than doubled since the 1970s and can have profound impacts on both a child’s physical and psychological health. Prior to initiating treatment, assessment of severity is important as many pediatric patients with less than 10% body surface area can be treated with topical medications, avoiding unnecessary risks for systemic therapy. This is a case of a 13-year-old female that presented with red, scaly rash for several years. She and her mother opted for UV-B phototherapy for treatment of her pediatric psoriasis.

Keywords

Pediatric psoriasis Topicals Corticosteroids Vitamin D analog 

References

  1. 1.
    Parisi R, Symmons DP, Griffiths CE, Ashcroft DM, Identification, Management of Psoriasis & Associated ComorbidiTy Project Team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.  https://doi.org/10.1038/jid.2012.339.CrossRefPubMedGoogle Scholar
  2. 2.
    Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62(6):979–87.  https://doi.org/10.1016/j.jaad.2009.07.029.CrossRefPubMedGoogle Scholar
  3. 3.
    Paller AS, Mercy K, Kwasny MJ, Choon SE, Cordoro KM, Girolomoni G, Menter A, Tom WL, Mahoney AM, Oostveen AM, Seyger MM. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol. 2013;149(2):166–76.  https://doi.org/10.1001/jamadermatol.2013.1078.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17(3):174–8.CrossRefGoogle Scholar
  5. 5.
    Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok PY, Menter A, Lathrop GM, Wise CA, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR, Collaborative Association Study of Psoriasis. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41(2):199–204.  https://doi.org/10.1038/ng.311.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Silverberg NB. Update on pediatric psoriasis, Part 2: Therapeutic management. Cutis. 2010;86(4):172–6.PubMedGoogle Scholar
  7. 7.
    Shah KN. Diagnosis and treatment of pediatric psoriasis: current and future. Am J Clin Dermatol. 2013;14(3):195–213.  https://doi.org/10.1007/s40257-013-0026-8.CrossRefPubMedGoogle Scholar
  8. 8.
    Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A, Etanercept Pediatric Psoriasis Study Group. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med. 2008;358(3):241–51.  https://doi.org/10.1056/NEJMoa066886.CrossRefPubMedGoogle Scholar
  9. 9.
    Landells I, Marano C, Hsu MC, Li S, Zhu Y, Eichenfield LF, Hoeger PH, Menter A, Paller AS, Taieb A, Philipp S, Szapary P, Randazzo B. Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study. J Am Acad Dermatol. 2015;73(4):594–603.  https://doi.org/10.1016/j.jaad.2015.07.002.CrossRefPubMedGoogle Scholar
  10. 10.
    van Geel MJ, Oostveen AM, Hoppenreijs EP, Hendriks JC, van de Kerkhof PC, de Jong EM, Seyger MM. Methotrexate in pediatric plaque-type psoriasis: long-term daily clinical practice results from the Child-CAPTURE registry. J Dermatolog Treat. 2015;26(5):406–12.  https://doi.org/10.3109/09546634.2014.996515.CrossRefPubMedGoogle Scholar
  11. 11.
    Pavlovsky M, Baum S, Shpiro D, Pavlovsky L, Pavlotsky F. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis? J Eur Acad Dermatol Venereol. 2011;25(6):727–9.  https://doi.org/10.1111/j.1468-3083.2010.03832.x.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Michael P. Lee
    • 1
  • Kevin K. Wu
    • 2
  • Jashin J. Wu
    • 3
  1. 1.Eastern Virginia Medical SchoolNorfolkUSA
  2. 2.Frank H. Netter MD School of Medicine at Quinnipiac UniversityNorth HavenUSA
  3. 3.Founder and CEODermatology Research and Education FoundationIrvineUSA

Personalised recommendations